XOMA

XOMA Corporation [XOMA] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

XOMA Stock Summary

Top 10 Correlated ETFs

XOMA

Top 10 Correlated Stocks

XOMA

In the News

XOMA Financial details

Company Rating
-
Market Cap
300.53M
Income
-48.74M
Revenue
4.76M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
13
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-6.97
Forward P/E
-
PEG
-0.38
P/S
54.74
P/B
2.28
P/C
-
P/FCF
-13.33
Quick Ratio
3.26
Current Ratio
3.34
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-4.25
EPS next Y
-
EPS next Q
-
EPS this Y
137.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
32.25%
Revenue last 5Y
-23.68%
Revenue Q/Q
120.84%
EPS Q/Q
264.58%
-
-
-
-
SMA20
-
SMA50
-19.23%
SMA100
-30%
Inst Own
-
Inst Trans
-
ROA
-28%
ROE
-30%
ROC
-0.25%
Gross Margin
83%
Oper. Margin
-638%
Profit Margin
-785%
Payout
-16%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
13.48-27.0
52W High
-18.04%
52W Low
+70.23%
RSI
56
Rel Volume
0.45
Avg Volume
20.75K
Volume
9.41K
Perf Week
12.34%
Perf Month
4.58%
Perf Quarter
-25.01%
Perf Half Y
-24.73%
-
-
-
-
Beta
0.589
-
-
Volatility
0.66%, 0.72%
Prev Close
4.49%
Price
22.13
Change
14.72%

Something similar

Top by Market Cap
M&M.NS
BRK-A
0YXG.L
TSLA
AAPL
Top Correlated ETFs
BETZ
ODDS
SCJ
EWY
GWX
Top Correlated Stocks
RNW
HMC
XENE
ESYJY
0T6G.L
Similar Market Cap
MGT.PA
FFNW
XESD.DE
BLW
LIN.PA

Company Profile

Healthcare Biotechnology
  • Volume Average 20.75K
  • Market Capitalization 300.53M
  • Employee 13
  • CEO Mr. Owen P. Hughes Jr.
  • Headquarters EmeryVille,CA,US
  • IPO Date 1986-06-06
  • Website https://www.xoma.com

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.